Total Payments
$14,651
2024 Payments
$2,532
Companies
21
Transactions
124
Medicare Patients
225
Medicare Billing
$35,449
Payment Breakdown by Category
Consulting$9,000 (61.4%)
Research$3,120 (21.3%)
Food & Beverage$2,497 (17.0%)
Other$20.54 (0.1%)
Education$13.40 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $9,000 | 2 | 61.4% |
| Unspecified | $3,120 | 2 | 21.3% |
| Food and Beverage | $2,497 | 118 | 17.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $20.54 | 1 | 0.1% |
| Education | $13.40 | 1 | 0.1% |
Payments by Type
General
$11,531
122 transactions
Research
$3,120
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $12,797 | 42 | $0 (2024) |
| CSL Behring | $546.36 | 28 | $0 (2024) |
| Akcea Therapeutics, Inc. | $243.76 | 7 | $0 (2021) |
| Eisai Inc. | $163.67 | 4 | $0 (2020) |
| JAZZ PHARMACEUTICALS INC. | $117.87 | 5 | $0 (2024) |
| NeuroPace, Inc. | $114.72 | 2 | $0 (2019) |
| Alexion Pharmaceuticals, Inc. | $108.41 | 1 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $74.86 | 4 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $74.73 | 4 | $0 (2020) |
| Biohaven Pharmaceuticals, Inc. | $64.66 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,532 | 12 | UCB, Inc. ($2,365) |
| 2023 | $10,106 | 21 | UCB, Inc. ($9,892) |
| 2022 | $640.09 | 26 | UCB, Inc. ($229.05) |
| 2021 | $504.13 | 33 | UCB, Inc. ($130.44) |
| 2020 | $370.77 | 20 | UCB, Inc. ($156.46) |
| 2019 | $409.81 | 7 | Akcea Therapeutics, Inc. ($151.96) |
| 2018 | $30.97 | 2 | NEUROPACE, INC. ($15.83) |
| 2017 | $57.16 | 3 | Novartis Pharmaceuticals Corporation ($36.62) |
All Payment Transactions
124 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/25/2024 | Neurelis, Inc. | VALTOCO (Drug) | Education | In-kind items and services | $13.40 | General |
| Category: EPILEPSY | ||||||
| 07/15/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Immunology | ||||||
| 06/27/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: Neurology | ||||||
| 06/13/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: NEUROLOGY | ||||||
| 06/03/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $24.67 | General |
| Category: NEUROLOGY | ||||||
| 05/23/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Neurology | ||||||
| 05/10/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: NEUROLOGY | ||||||
| 05/09/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: EPILEPSY | ||||||
| 04/23/2024 | UCB, Inc. | — | — | In-kind items and services | $2,300.00 | Research |
| Study: Perceptions of Health Disparities Among Neurologists Treating Black Patients With Epilepsy- A Survey Study in the United States | ||||||
| 03/15/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $26.31 | General |
| Category: NEUROLOGY | ||||||
| 03/14/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: Neurology | ||||||
| 03/01/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $25.48 | General |
| Category: NEUROLOGY | ||||||
| 12/18/2023 | UCB, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,500.00 | General |
| 09/12/2023 | UCB, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,500.00 | General |
| 08/15/2023 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $4.56 | General |
| Category: Immunology | ||||||
| 08/09/2023 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $7.69 | General |
| Category: Immunology | ||||||
| 06/07/2023 | UCB, Inc. | — | — | In-kind items and services | $820.00 | Research |
| Study: Health Disparities in Black Patients Living With Epilepsy: Findings From a Survey of US Neurologists | ||||||
| 06/01/2023 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Immunology | ||||||
| 05/11/2023 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: Immunology | ||||||
| 05/11/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Neurology | ||||||
| 05/09/2023 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $8.64 | General |
| Category: Immunology | ||||||
| 04/28/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: Neurology | ||||||
| 04/27/2023 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Immunology | ||||||
| 04/13/2023 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Immunology | ||||||
| 03/24/2023 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $27.57 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Perceptions of Health Disparities Among Neurologists Treating Black Patients With Epilepsy- A Survey Study in the United States | UCB, Inc. | $2,300 | 1 |
| Health Disparities in Black Patients Living With Epilepsy: Findings From a Survey of US Neurologists | UCB, Inc. | $820.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 29 | 42 | $18,616 | $5,124 |
| 2022 | 6 | 118 | 154 | $48,090 | $13,389 |
| 2021 | 3 | 40 | 59 | $26,283 | $7,390 |
| 2020 | 2 | 38 | 64 | $35,368 | $9,546 |
Total Patients
225
Total Services
319
Medicare Billing
$35,449
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 17 | 27 | $15,372 | $4,149 | 27.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 12 | 15 | $3,245 | $974.74 | 30.0% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2022 | 22 | 35 | $20,965 | $5,562 | 26.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 31 | 32 | $10,008 | $3,208 | 32.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 13 | 13 | $6,006 | $1,848 | 30.8% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 24 | 24 | $4,128 | $1,011 | 24.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 13 | 15 | $3,513 | $949.83 | 27.0% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2022 | 15 | 35 | $3,470 | $810.08 | 23.3% |
| 95720 | Continuous measurement of brain wave activity with video (veeg), 12-26 hours, with health care professional analysis, interpretation and report | Facility | 2021 | 15 | 32 | $19,168 | $4,909 | 25.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 11 | 13 | $3,965 | $1,477 | 37.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 14 | 14 | $3,150 | $1,004 | 31.9% |
| 95720 | Continuous measurement of brain wave activity with video (veeg), 12-26 hours, with health care professional analysis, interpretation and report | Facility | 2020 | 24 | 50 | $29,950 | $8,077 | 27.0% |
| 95718 | Continuous measurement of brain wave activity with video (veeg), 2-12 hours, with health care professional analysis, interpretation and report | Facility | 2020 | 14 | 14 | $5,418 | $1,470 | 27.1% |
About Dr. Ima Ebong, MD
Dr. Ima Ebong, MD is a Clinical Neurophysiology healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2013. The National Provider Identifier (NPI) number assigned to this provider is 1891037230.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ima Ebong, MD has received a total of $14,651 in payments from pharmaceutical and medical device companies, with $2,532 received in 2024. These payments were reported across 124 transactions from 21 companies. The most common payment nature is "Consulting Fee" ($9,000).
As a Medicare-enrolled provider, Ebong has provided services to 225 Medicare beneficiaries, totaling 319 services with total Medicare billing of $35,449. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Clinical Neurophysiology
- Other Specialties Student in an Organized Health Care Education/Training Program
- Location Lexington, KY
- Active Since 03/24/2013
- Last Updated 05/02/2022
- Taxonomy Code 2084N0600X
- Entity Type Individual
- NPI Number 1891037230
Products in Payments
- Briviact (Drug) $576.74
- Hizentra (Biological) $546.36
- TEGSEDI (Drug) $243.76
- Fycompa (Drug) $163.67
- EPIDIOLEX (Drug) $117.87
- RNS System (Device) $114.72
- ULTOMIRIS (Biological) $108.41
- NURTEC ODT (Drug) $98.22
- AUSTEDO (Drug) $74.86
- Rystiggo (Drug) $64.74
- Gamunex-C (Biological) $60.21
- APTIOM (Drug) $57.62
- VYVGART (Drug) $46.22
- AIMOVIG (Biological) $38.11
- GILENYA (Drug) $36.62
- Nayzilam (Drug) $35.62
- OXTELLAR XR (Drug) $28.02
- VALTOCO (Drug) $27.26
- FYCOMPA (Drug) $24.67
- AMPYRA (Drug) $20.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Clinical Neurophysiology Doctors in Lexington
Dr. Warren Chumley, Md, MD
Clinical Neurophysiology — Payments: $389,416
Clinical Neurophysiology $389,416
Dr. Greg Anderson, Md, MD
Clinical Neurophysiology — Payments: $44,121
Clinical Neurophysiology $44,121
Stephen Ryan, Md, MD
Clinical Neurophysiology — Payments: $213.92
Clinical Neurophysiology $213.92
Kevin Nelson, Md, MD
Clinical Neurophysiology — Payments: $95.04
Clinical Neurophysiology $95.04